Merck, Actover’s reliable partner in the transfer of the most advanced pharmaceutical technologies to Iran

Visual Report on the Introduction of Actonib and Its application in Dermatology

25th May; “World Thyroid Day”

The presence of Actoverco at 6th job fair

Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran

Selected Titles

Read More
عید فطر - تلگرام - انگلیسی -04

Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity

By Tina Rezaei | 1 April 2025
4R4A68781-2048x1365

First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment

By Tina Rezaei | 9 March 2025
Ehsan-05

Welcoming Nowruz with “Kindness and Generosity”

By Tina Rezaei | 5 March 2025
World Epilepsy Day

World Epilepsy Day

By Tina Rezaei | 11 February 2025
تامنیل بارداری-02

Pregnancy Awareness Promotion Week

By Tina Rezaei | 3 February 2025
4R4A061511-2048x1365

Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis

By Tina Rezaei | 27 January 2025
M_HA2443

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

By Tina Rezaei | 29 December 2024
4R4A3160

Holding the 21st MS Congress of Iran with the participation of Actoverco

By Tina Rezaei | 15 December 2024
M_HA1634

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

By Tina Rezaei | 11 December 2024
4R4A2655-Pano

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

By Tina Rezaei | 9 December 2024

The latest videos and pictures

4R4A2655-Pano

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

9 December 2024
IMGM0506

Visual Report on the Introduction of “gynati” and “prequin”

10 August 2024
actonib launch

Visual Report on the Introduction of Actonib and Its application in Dermatology

31 July 2024
HY6A3173

Neurostyle Launch Event

14 July 2024
nahaleh naraghi

Interview with Nahaleh Naraqi about Actoverco social responsibilities

5 June 2024
__HA0603

Iran Pharma International Exhibition 2021

By Actoverco | 8 February 2022
__HA0325

Iran Bio Congress

By Actoverco | 8 February 2022
iranbio

Video report of the last day of Iran Bio Congress

By Actoverco | 8 February 2022
Sputnik- reza mostofi

Sputnik vaccine

By Actoverco | 8 February 2022
__HA0325

Iran Bio Congress

By Actoverco | 8 February 2022

The latest news and articles

Read More
nahaleh naraghi ceo of actoverco
No Comments

With the lifting of sanctions, many announced their readiness to work with “Actoverco

19 January 2016 | Author:Actoverco

We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.

Read More loader

Conferences and Exhibitions

Read More
MIL14860

Congress

By Actoverco | 1 November 2021
__HA0325

2021 Pharmax Middle East Festival

By Actoverco | 19 October 2021
2021 Pharmax Middle East Festival will be held from 19 to 21 October 2021 in Hall 5 (Nations)...
__HA0603

6th exhibition of Iran Pharma (IPH) opening ceremony

By Actoverco | 11 October 2021
The opening ceremony of the 6th Iran Pharma Exhibition, the largest international specialized gathering of the country's pharmaceutical...
MIL14688

Introduction of new drugs

By Actoverco | 3 October 2021